APR 21, 2021 11:59 AM PDT

Dietary Supplement Successfully Treats Mice with Schizophrenia

WRITTEN BY: Annie Lennon

Researchers from the University of Tokyo have found that betaine, a dietary supplement found in sugar beets, reduces behavioural symptoms of schizophrenia in mice with a genetic predisposition to the condition.  

The kinesin superfamily of genes in mammals mostly encodes motor protons that move materials throughout the cell. Genetic studies of people diagnosed with schizophrenia show that people with the condition tend to have variations in the kinesin family 3b (kif3b) gene as well as another involved in the body’s internal synthesis of betaine. 

As such, mouse models of schizophrenia usually have only one functional copy of the kif3b gene. These mice tend to avoid social interactions and have similar reactions to humans in tests measuring how startled they become after sudden, loud sounds proceeded by quieter ones. 

For the study, researchers raised mice with this schizophrenia model on betaine supplements at three times the normal dietary requirement. In doing so, the mice were observed to have normal behaviour, meaning that the supplement may be able to treat symptoms of schizophrenia.

 To understand how this may work, the researchers then grew nerve cells with the kif3b mutation in the lab and added fluorescent labels to them to map their development. These kif3b mutant neurons tended to have more branches than regular neurons, something also observed in brain samples donated by patients with schizophrenia regardless of their treatments. 

In observing the cells more closely, the researchers found that the presence of skeleton components in neuron development known as tubulin and actin differed from that observed in normal cells. A chemical analysis of the brains of kif3b mutant mice and human schizophrenia patients revealed damage to CRMP2, a protein used for the assembly of actin. 

As such, the researchers proposed that betaine may help patients with schizophrenia by preventing a kind of chemical damage, known as carbonyl stress, that leads to CRMP2 dysfunction. This comes especially as postmortem brain scans have found that CRMP2 is the protein that undergoes the most carbonyl stress in the brain. 

By protecting CRMP2 from damage, the researchers propose that betaine may allow kif3b mutant neurons to build proper cell structures. With these structures built, the remaining functional KIF3B proteins can then transport cargo around the cells, something that, once extrapolated, may reduce some symptoms of schizophrenia. 

While the researchers don’t encourage people to take betaine supplements without a doctor’s recommendation, they say that one day, after further tests and trials, they may be able to be repurposed to treat schizophrenia. This comes especially as the supplement is already known to be safe from pre-existing clinical use. 

 

Sources: Neuroscience NewsCell

About the Author
  • Science writer with a keen interest in behavioral biology, consciousness medicine and technology. Her current focus is how the interplay of these fields can create meaningful interactions, products and environments.
You May Also Like
JAN 16, 2021
Drug Discovery & Development
Scientists Discover Contents of an Ancient Mayan Drug Containers
JAN 16, 2021
Scientists Discover Contents of an Ancient Mayan Drug Containers
Washington State University researchers found a non-tobacco plant in containers of an ancient Maya drug. "While it ...
FEB 18, 2021
Drug Discovery & Development
Weight-Loss Hormone Prevents Muscle-Loss
FEB 18, 2021
Weight-Loss Hormone Prevents Muscle-Loss
Scientists from the University of Southern California Leonard Davis School of Gerontology, show that a hormone known to ...
FEB 12, 2021
Drug Discovery & Development
Compound Reverses ALS Neuron Damage
FEB 12, 2021
Compound Reverses ALS Neuron Damage
Scientists at Northwestern University identify the first compound that removes the ongoing degeneration of upper motor n ...
MAR 04, 2021
Infographics
All You Need to Know about COVID-19 Vaccines
MAR 04, 2021
All You Need to Know about COVID-19 Vaccines
After over a year lockdowns brought on by the pandemic, hopes for returning to something even similar to ' ...
MAR 04, 2021
Drug Discovery & Development
How Placebo Drugs for Pain Work in the Brain
MAR 04, 2021
How Placebo Drugs for Pain Work in the Brain
Researchers from Dartmouth College have found that pain relief drugs that work via the placebo effect reduce pain-relate ...
MAY 11, 2021
Genetics & Genomics
Gene Therapy Trial for Severe Immune Disorder is Successful
MAY 11, 2021
Gene Therapy Trial for Severe Immune Disorder is Successful
Severe combined immunodeficiency (SCID), which virtually eliminates a patient's immune system, and severely affects thei ...
Loading Comments...